Lead Anemia Treatment
Anemia
UnknownActive
Key Facts
About InkVivo
InkVivo Technologies is a 2020-founded, ETH Zurich spin-off based in Lausanne, Switzerland, focused on advanced drug delivery. The company has developed a proprietary, scalable polymer platform designed for the reformulation of existing drugs to enhance bioavailability, reduce dosing frequency, and minimize side effects. Having secured CHF 1.1M in pre-seed funding, InkVivo is advancing a lead anemia treatment and exploring partnerships while preparing for a US roadshow in 2025. Its business model centers on partnering with pharma companies to create new IP and extend product lifecycles through improved formulations.
View full company profileTherapeutic Areas
Other Anemia Drugs
| Drug | Company | Phase |
|---|---|---|
| PT-1 EPO | Imagine Pharma | Pre-clinical |
| Undisclosed Program | Scholar Rock Holding | Discovery |